Physician profile
Jason Hymowitz
NPI 1912404237
$5,969.37
in general payments reported to CMS, 2019-2025
12 companies · $1,409 in 2025
The $1,409 reported for 2025 was more than what 85% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $197 · 2022: $2,303 · 2023: $754 · 2024: $1,307 · 2025: $1,409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,469.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $2,592.58 | 2021-2025 | |
| Stryker Corporation | $1,303.91 | 2021-2025 | Infinity Adaptis, Prostep Mica, T2 |
| Zimmer Biomet Holdings, INC. | $599.83 | 2022-2024 | Tapestry, Ti Cannulated Screws |
| Globus Medical, INC. | $382.31 | 2023-2025 | Distal Femur Plate System, Ankle Fracture System, Small Frag Plating System |
| Treace Medical Concepts, INC. | $335.26 | 2022-2025 | |
| Kerecis Limited | $303.50 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Arthrex, INC. | $278.08 | 2022 | |
| Tactile Systems Technology INC | $82.24 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Integra Lifesciences Corporation | $31.85 | 2021 | |
| Hydrofera LLC | $22.54 | 2024 | Hydrofera Blue |
| Paragon 28, INC. | $21.09 | 2022 | |
| Smith+Nephew, INC. | $16.18 | 2024 | Renasys Touch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Hymowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.